NEOG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Neogen Corp (NEOG) is not a strong buy at this moment for a beginner investor with a long-term strategy. While there are some positive indicators, such as hedge fund buying and a bullish moving average trend, the company's recent financial performance shows significant declines in revenue, net income, and EPS. Additionally, the lack of recent news catalysts and the absence of strong proprietary trading signals suggest that waiting for better entry points or further confirmation of a turnaround is prudent.
The MACD is negative and expanding downward, indicating bearish momentum. RSI is neutral at 69.597, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support and resistance levels are Pivot: 10.969, R1: 11.371, S1: 10.568, R2: 11.619, S2: 10.32. The stock is trading near resistance levels in pre-market, suggesting limited short-term upside.
Hedge funds have significantly increased their buying activity, up 999.08% over the last quarter. Analysts have raised price targets recently, with Guggenheim increasing its target to $12 and maintaining a Buy rating.
The company's financial performance has deteriorated significantly, with revenue, net income, and EPS all showing sharp declines YoY. No recent news or congress trading data is available to act as a catalyst. The stock is down 2.74% in pre-market trading, reflecting negative sentiment.
In Q2 2026, Neogen's revenue dropped by 2.84% YoY to $224.69M. Net income plummeted by 96.51% YoY to -$15.92M, and EPS fell by 96.67% YoY to -$0.07. Gross margin also declined by 3.89% YoY to 37.29%.
Analysts are cautiously optimistic. Guggenheim raised its price target to $12 from $8 and maintained a Buy rating, citing improved portfolio performance and cost actions. CJS Securities upgraded the stock to Outperform with a $10 price target. However, Guggenheim noted that one quarter does not make a trend.
